ArticleCancer medicine2023

Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study.

Yi-Kun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.